Note from the Boss

Quote

anonymous

Guest
Guys,
If you cant hit your number dont complain about your jobs.
We have a lot of people who can take your job.
Best,
Mike P

Valeant's female-libido drug Addyi won't hit revenue targets in 2016
Mr. Pearson said that Addyi, a drug that aims to boost a woman’s libido, won’t hit sales of $100 million to $115 million that Valeant had predicted earlier.

“Hopefully we’ll get to that level,” Mr. Pearson said, but didn’t give any guidance on when that could happen.

In August, Valeant announced a deal to buy Sprout Pharmaceuticals Inc., which manufactures Addyi. It spent $1 billion on that deal.
 






Hey Mike P,
You are easily replaced as well. To claim you didn't even know about your golden parachute of 200 million on the investor call is pathetic. You and your management team have been exposed as the sorriest group of executives pharma has seen! Oh and you might want to join Toastmasters... you are a bumbling fool when you speak.
 






Walgreens conference call today..gotta love the message from Ray that we need not worry about Valeant's financials...the business is solid. Ray.. whatever you are smoking, pass it around. News flash....this place is a mess and you are one of the reasons why!
 






Ray here: the stock is great and the company is great. It will never go below 80. I mean 70.

I mean 60, 50, 40.... Nothing to see folks. keep on selling this new wonder drug
 












Top Bottom
Back
Quote